as on October 30, 2025 at 1:29 am IST
Day's Low
Day's High
0.66%
Downside
1.59%
Upside
52 Week's Low
52 Week's High
16.23%
Downside
184.80%
Upside
Check Telix Pharmaceuticals Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.6B
EPS (TTM)
0.015
Dividend Yield
0.00%
PE Ratio (TTM)
538.5
Industry PE ratio
0PEG Ratio
0Return On Equity TTM
3.14%
Track how Telix Pharmaceuticals Ltd P/E has moved over time to understand its valuation trends.
Telix Pharmaceuticals Ltd in the last 5 years
Lowest (75.57x)
September 30, 2025
Industry (0.00x)
October 30, 2025
Today (538.50x)
October 30, 2025
Highest (114.85x)
March 31, 2025
Today’s Price to Earnings Ratio: 538.50x
Compare market cap, revenue, PE, and other key metrics of Telix Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $3.6B | NA | 538.5 | 1.63% | |
| BUY | $62.4B | 291.63% | -505.15 | -12.96% | |
| NA | $36.4B | NA | NA | -3.89% | |
| BUY | $108.3B | 100.24% | 30.02 | 31.86% | |
| BUY | $69.4B | 20.12% | 15.7 | 32.13% |
Search interest for Telix Pharmaceuticals Ltd Stock has decreased by -39% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Dip
![]()
In the last 6 months, TLX stock has moved down by -38.9%
| Organisation | Telix Pharmaceuticals Ltd |
| Headquarters | 55 Flemington Road, North Melbourne, VIC, Australia, 3051 |
| CEO | Dr. Christian P. Behrenbruch BEng(Hons), DPhil(Oxon), GAICD, J.D., M.B.A., MBA |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. David N. Cade M.B.A., M.D., MBBS | Group Chief Medical Officer |
Dr. Paul Schaffer | Chief Technology Officer |
Mr. Craig Ulrick | Chief Information Officer |
Dr. Michael Wheatcroft B.Sc., BSc(Hons), Ph.D., Ph.D., (Cantab) | Chief Scientist |
Ms. Kyahn Williamson B.A. | Senior Vice President of Corporate Communications & Investor Relations |
Dr. Christian P. Behrenbruch BEng(Hons), DPhil(Oxon), GAICD, J.D., M.B.A., MBA | Co-Founder, MD, Group CEO & Executive Director |
Mr. Darren Smith B.Bus., FCPA, M.B.A. | Group Chief Financial Officer |
Mr. Darren Patti Pharm.D. | Group Chief Operating Officer |
Dr. Andreas Kluge M.D., Ph.D. | Chief Medical Advisor |
Mr. Richard Valeix M.B.A. | Chief Executive Officer of Telix Therapeutics |
Telix Pharmaceuticals Ltd share price today is $10.66 as on at the close of the market. Telix Pharmaceuticals Ltd share today touched a day high of $10.83 and a low of $10.59.
Telix Pharmaceuticals Ltd share touched a 52 week high of $30.36 on and a 52 week low of $8.93 on . Telix Pharmaceuticals Ltd stock price today i.e. is closed at $10.66,which is 64.89% down from its 52 week high and 19.37% up from its 52 week low.
Telix Pharmaceuticals Ltd market capitalisation is $0.00T as on .
Indian investors can start investing in Telix Pharmaceuticals Ltd (TLX) shares with as little as ₹88.178 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.78 in Telix Pharmaceuticals Ltd stock (as per the Rupee-Dollar exchange rate as on ).
Based on Telix Pharmaceuticals Ltd share’s latest price of $10.66 as on October 30, 2025 at 1:29 am IST, you will get 0.9381 shares of Telix Pharmaceuticals Ltd. Learn more about
fractional shares .